Home / Netherlands / DSM-Firmenich AG
DSM-Firmenich AG
Short position disclosed on September 14, 2026.
3.48% of the capital sold short
3 disclosing funds
74 disclosures on record
CH1216478797 ISIN code
Evolution of the disclosed total
0%1%2%3%4%
Oct 2025Jan 2026Apr 2026Jul 2026
October 24, 2023 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Ilex Capital Partners (UK) LLP | 2.10% | +1.27 pt | July 31, 2026 | |
| Marshall Wace LLP | 0.78% | new | September 14, 2026 | |
| Capital Fund Management S.A. | 0.60% | new | September 7, 2026 |
In the United States DSMFF (OTC): 566,600 shares sold short on August 31, 2026. FINRA names no fund.
On the other side: the funds that hold DSM-Firmenich AG Titelia
Get the moves on DSM-Firmenich AG by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
Download 74 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the Netherlands
- Akzo Nobel N.V. 9.32% of the capital sold short
- Signify N.V. 8.62% of the capital sold short
- Pharming Group N.V. 7.39% of the capital sold short
- Imcd N.V. 4.86% of the capital sold short
- The Magnum Ice Cream Company N.V. 4.40% of the capital sold short
- Fugro N.V. 3.75% of the capital sold short
- Basic-Fit N.V. 3.43% of the capital sold short
- Universal Music Group N.V. 2.70% of the capital sold short
- Alfen N.V. 2.11% of the capital sold short
- NSI N.V. 2.09% of the capital sold short
- Arcadis N.V. 1.72% of the capital sold short
- Havas N.V. 1.70% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, DSM-Firmenich AG, source AFM, data as at September 14, 2026, https://www.quivad.com/action/dsm-firmenich-ag